DE60037602D1 - Herstellung einer polymorphen Form eines Thiazolidindionderivates - Google Patents

Herstellung einer polymorphen Form eines Thiazolidindionderivates

Info

Publication number
DE60037602D1
DE60037602D1 DE60037602T DE60037602T DE60037602D1 DE 60037602 D1 DE60037602 D1 DE 60037602D1 DE 60037602 T DE60037602 T DE 60037602T DE 60037602 T DE60037602 T DE 60037602T DE 60037602 D1 DE60037602 D1 DE 60037602D1
Authority
DE
Germany
Prior art keywords
preparation
polymorphic form
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60037602T
Other languages
English (en)
Other versions
DE60037602T2 (de
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60037602(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909472.4A external-priority patent/GB9909472D0/en
Priority claimed from GBGB9912197.2A external-priority patent/GB9912197D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE60037602D1 publication Critical patent/DE60037602D1/de
Application granted granted Critical
Publication of DE60037602T2 publication Critical patent/DE60037602T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
DE60037602T 1999-04-23 2000-04-19 Herstellung einer polymorphen Form eines Thiazolidindionderivates Expired - Fee Related DE60037602T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9909472 1999-04-23
GBGB9909472.4A GB9909472D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912197.2A GB9912197D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
GB9912197 1999-05-25

Publications (2)

Publication Number Publication Date
DE60037602D1 true DE60037602D1 (de) 2008-02-07
DE60037602T2 DE60037602T2 (de) 2009-01-08

Family

ID=26315460

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60004658T Expired - Fee Related DE60004658T2 (de) 1999-04-23 2000-04-19 Thiazolidindionderivat und seine verwendung als antidiabetikum
DE60037602T Expired - Fee Related DE60037602T2 (de) 1999-04-23 2000-04-19 Herstellung einer polymorphen Form eines Thiazolidindionderivates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60004658T Expired - Fee Related DE60004658T2 (de) 1999-04-23 2000-04-19 Thiazolidindionderivat und seine verwendung als antidiabetikum

Country Status (40)

Country Link
US (2) US6815457B1 (de)
EP (3) EP1903043A1 (de)
JP (1) JP2002543075A (de)
KR (1) KR100744359B1 (de)
CN (1) CN1208335C (de)
AP (1) AP1495A (de)
AR (2) AR023564A1 (de)
AT (2) ATE382046T1 (de)
AU (1) AU765498B2 (de)
BG (1) BG65427B1 (de)
BR (1) BR0009934A (de)
CA (1) CA2370258A1 (de)
CO (1) CO5170424A1 (de)
CY (1) CY1107238T1 (de)
CZ (1) CZ20013799A3 (de)
DE (2) DE60004658T2 (de)
DK (2) DK1173434T3 (de)
DZ (1) DZ3155A1 (de)
EA (1) EA004534B1 (de)
ES (2) ES2298327T3 (de)
HK (2) HK1045154B (de)
HR (1) HRP20010773B1 (de)
HU (1) HUP0200929A3 (de)
IL (1) IL146110A0 (de)
MA (1) MA26785A1 (de)
MX (1) MXPA01010820A (de)
MY (1) MY128007A (de)
NO (1) NO320589B1 (de)
NZ (1) NZ515163A (de)
OA (1) OA11871A (de)
PE (1) PE20010040A1 (de)
PL (1) PL351686A1 (de)
PT (2) PT1284268E (de)
RS (1) RS50114B (de)
SK (1) SK286423B6 (de)
TR (1) TR200103061T2 (de)
TW (1) TW591027B (de)
UA (1) UA67843C2 (de)
UY (1) UY26120A1 (de)
WO (1) WO2000064892A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) * 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
DK1173434T3 (da) 1999-04-23 2003-12-08 Smithkline Beecham Plc Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
PE20010044A1 (es) * 1999-04-23 2001-03-10 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
IL155036A0 (en) * 2000-09-26 2003-10-31 Reddy Research Foundation Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2003050116A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
AU2002352479A1 (en) * 2001-12-20 2003-07-09 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (de) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphe Formen von Rosiglitazon Maleat
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (de) * 2004-01-28 2006-10-11 Usv Limited Verfahren zur herstellung von 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]phenylmethyl]thiazolidin-2,4-dionmaleat
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (de) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Verfahren zur Herstellung fester Dosierungsformen von Rosiglitazonmaleat

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288095B1 (en) 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US20010044458A1 (en) * 1994-02-10 2001-11-22 Smithkline Beechamp P.L.C. Use of insulin sensitisers for treating renal diseases
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
SG47100A1 (en) 1994-02-10 1998-03-20 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6153632A (en) * 1997-02-24 2000-11-28 Rieveley; Robert B. Method and composition for the treatment of diabetes
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US20020028768A1 (en) * 1997-06-18 2002-03-07 Smithkline Beecham P.L.C. Treatment of diabetes with rosiglitazone and insulin
KR20010013845A (ko) 1997-06-18 2001-02-26 피터 기딩스 티아졸리딘디온 및 알파-글루코시다제 억제제를 사용한당뇨병의 치료
WO1998057649A1 (en) 1997-06-18 1998-12-23 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
ATE355840T1 (de) 1997-06-18 2007-03-15 Smithkline Beecham Plc Behandlung der diabetes mit thiazolidindione und metformin
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
GB9712866D0 (en) 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
US20020045649A1 (en) * 1997-07-18 2002-04-18 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione and sulphonylurea
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
PE20010044A1 (es) 1999-04-23 2001-03-10 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
DK1173434T3 (da) 1999-04-23 2003-12-08 Smithkline Beecham Plc Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
WO2000064893A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
IL155036A0 (en) 2000-09-26 2003-10-31 Reddy Research Foundation Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
NO20015149D0 (no) 2001-10-22
CA2370258A1 (en) 2000-11-02
WO2000064892A3 (en) 2001-01-25
AR023568A1 (es) 2002-09-04
BG106119A (en) 2002-05-31
OA11871A (en) 2006-03-27
KR20020028873A (ko) 2002-04-17
HK1045154A1 (en) 2002-11-15
CY1107238T1 (el) 2012-11-21
NZ515163A (en) 2004-02-27
DZ3155A1 (fr) 2000-11-02
ES2204557T3 (es) 2004-05-01
RS50114B (sr) 2009-03-25
DK1173434T3 (da) 2003-12-08
MA26785A1 (fr) 2004-12-20
AP1495A (en) 2005-11-30
EP1284268B1 (de) 2007-12-26
TW591027B (en) 2004-06-11
BR0009934A (pt) 2002-06-04
US6815457B1 (en) 2004-11-09
SK286423B6 (sk) 2008-09-05
US20040092555A1 (en) 2004-05-13
WO2000064892A2 (en) 2000-11-02
SK14912001A3 (sk) 2002-02-05
PT1173434E (pt) 2003-12-31
HK1055293A1 (en) 2004-01-02
PL351686A1 (en) 2003-06-02
HUP0200929A2 (en) 2002-08-28
CN1355801A (zh) 2002-06-26
DE60037602T2 (de) 2009-01-08
HRP20010773A2 (en) 2002-10-31
CZ20013799A3 (cs) 2002-04-17
DK1284268T3 (da) 2008-04-28
EP1284268A1 (de) 2003-02-19
UY26120A1 (es) 2000-12-29
CO5170424A1 (es) 2002-06-27
JP2002543075A (ja) 2002-12-17
CN1208335C (zh) 2005-06-29
EP1173434B1 (de) 2003-08-20
DE60004658D1 (de) 2003-09-25
ATE382046T1 (de) 2008-01-15
PE20010040A1 (es) 2001-03-10
AR023564A1 (es) 2002-09-04
EA004534B1 (ru) 2004-06-24
MXPA01010820A (es) 2002-06-04
AU4130600A (en) 2000-11-10
PT1284268E (pt) 2008-03-10
ES2298327T3 (es) 2008-05-16
IL146110A0 (en) 2002-07-25
EP1903043A1 (de) 2008-03-26
HUP0200929A3 (en) 2004-03-29
EA200101119A1 (ru) 2002-04-25
YU75201A (sh) 2004-09-03
TR200103061T2 (tr) 2002-05-21
ATE247653T1 (de) 2003-09-15
KR100744359B1 (ko) 2007-07-30
NO20015149L (no) 2001-12-17
EP1173434A2 (de) 2002-01-23
NO320589B1 (no) 2005-12-27
AU765498B2 (en) 2003-09-18
UA67843C2 (uk) 2004-07-15
HK1045154B (zh) 2004-06-25
HRP20010773B1 (en) 2005-06-30
BG65427B1 (bg) 2008-07-31
DE60004658T2 (de) 2004-06-24
MY128007A (en) 2007-01-31

Similar Documents

Publication Publication Date Title
DE60037602D1 (de) Herstellung einer polymorphen Form eines Thiazolidindionderivates
DE60037395D1 (de) Herstellung eines halbleiter-bauelementes
PL395097A1 (pl) Sposób wytwarzania związku o wzorze A stanowiącego pochodną tiofenu
DE60029295D1 (de) Verfahren zur Herstellung eines basischen wasserabsorbierenden Mittels
DE60037443D1 (de) Herstellung eines kondensators durch bildung einer mit halbkugel-korn-silizium versehenen siliziumelektrode
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
DE69916232D1 (de) Zusammensetzung zur Herstellung einer Metall-Keramik-Beschichtung
DE10081019T1 (de) Verfahren zur Herstellung einer Kautschukzusammensetzung
DE60236171D1 (de) Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats
DE60109545D1 (de) Verfahren zur Herstellung einer Aromazusammensetzung auf Pilzbasis
DE60003470D1 (de) Verfahren zur Herstellung eines Triarylamindimeres
DE60026184D1 (de) Verfahren zur Herstellung eines kristallinen Gegenstandes
MA26844A1 (fr) Nouveaux derives de la thiazolidinedione comme agents antidiabetiques
DE69920553D1 (de) Flansch eines hohlen Gegenstandes
EE05609B1 (et) Dibensotiasepiiniderivaatide valmistamismeetod
DE50009162D1 (de) Rotormast eines hubschraubers
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
DE60133746D1 (de) Tartratsalze eines thiazolidinedione derivats
DE59803460D1 (de) Vorbereitung eines watteendes einer wattebahn
NO20000965L (no) FremgangsmÕte for fremstilling av veksthormon-utskillende forbindelser
DE60021956D1 (de) Herstellung einer Gasflasche
EE200300204A (et) Meetod distamütsiini derivaadi valmistamiseks
ATE384059T1 (de) Tartratsalze eines thiazolidinedione derivats
SI1284268T1 (sl) Priprava polimorfnih oblik derivatov tiazolidinedion-a
EE200100407A (et) Bensotiasoloonühendi valmistamise uudne meetod

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BLACKLER, PAUL DAVID JAMES, NEAR LEIGH TONBRID, GB

Inventor name: GILES, ROBERT GORDON, NEAR LEIGH TONBRIDGE, KE, GB

Inventor name: SASSE, MICHAEL JOHN, NEAR LEIGH TONBRIDGE, KEN, GB

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee